Abstract CT158: A Dose Escalation and Cohort Expansion Study of the CDK9 Inhibitor KB-0742 in Relapsed, Refractory and Transcriptionally Addicted Solid TumorsMiguel Villalona Calero,Mark Agulnik,Monica Mita,Alain Mita,Noah Federman,Drew Rasco,David Spigel,Jia Luo,Glenn Hanna,Gregory Cote, Mohamad A. Salkeni,Rashmi Chugh, Natraj R. Ammakkanavar, Satish A. Shah,Amol Rao,Kamalesh Kumar Sankhala,Richard E. Cutler,Tressa Hood,Luis Carvajal,Crystal MacKenzie,Charles Lin,Jorge DiMartino, Elizabeth A. Olek,Brian Van TineCancer Research(2024)引用 0|浏览28暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要